Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 552.47 USD -0.26% Market Closed
Market Cap: 12.5B USD

Wall Street
Price Targets

MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast MDGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDGL is 573.11 USD with a low forecast of 460.56 USD and a high forecast of 682.5 USD.

Lowest
Price Target
460.56 USD
17% Downside
Average
Price Target
573.11 USD
4% Upside
Highest
Price Target
682.5 USD
24% Upside
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
086900
Medy Tox Inc
9% Upside
HPHA
Heidelberg Pharma AG
63% Upside
RPTX
Repare Therapeutics Inc
42% Upside
ADOC
Adocia SA
123% Upside
BIOPOR
Bioporto A/S
274% Upside
GBIO
Generation Bio Co
462% Upside
KURN
Kuros Biosciences AG
16% Upside
AVCT
Avacta Group PLC
8% Upside

Revenue
Forecast

Revenue Estimate
Madrigal Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Madrigal Pharmaceuticals Inc's revenue is 28%. The projected CAGR for the next 3 years is 128%.

28%
Past Growth
128%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDGL's stock price target?
Price Target
573.11 USD

According to Wall Street analysts, the average 1-year price target for MDGL is 573.11 USD with a low forecast of 460.56 USD and a high forecast of 682.5 USD.

What is Madrigal Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
128%

For the last 13 years the compound annual growth rate for Madrigal Pharmaceuticals Inc's revenue is 28%. The projected CAGR for the next 3 years is 128%.

Back to Top